GGrantIndex
Sort

40,608 grants matching prostate cancer

Pure Flavonolignans from S. marianum in Prostate Cancer

$382,273
Research Triangle Institute · R01 · FY2005 · CA

Glucocorticoids &Vitamin D: Role In Anti-Tumor Effects

$382,266
Roswell Park Cancer Institute Corp · R01 · FY2005 · CA

Cancer and Leukemia Group B - The Ohio State University

$382,209
Ohio State University · U10 · FY2004 · CA

Controlled Release of Macromolecules

$382,200
Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2015 · EB

Laminin Dysregulation and Prostate Cancer

$382,198
Stephen R Plymate · University Of Washington · U54 · FY2009 · CA

Chemoresistance in Renal Cell Cancer

$382,188
Ohio State University · R01 · FY2002 · CA

High-intensity focused ultrasound (HIFU) energized functionalized nanoparticles mediated enhanced thermal ablation of tumors

$382,179
Rupak K Banerjee · University Of Cincinnati Main Campus · · FY2021 · ENG

Genetic & Metabolic Dissection of the CaMKKbeta Signaling Axis in Prostate Cancer

$382,168
Daniel Edward Frigo · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

NM MINORITY-BASED COMMUNITY CLINICAL ONC. PROGRAM

$382,151
University Of New Mexico · U10 · FY2001 · CA

High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment

$382,130
Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2019 · CA

THERAPEUTIC VALUE OF PLK1 KNOCKDOWN IN COMBINATION WITH PROSTATE CANCER DRUGS IN PIM-1 OVEREXPRESSING PROSTATE CANCER CELLS

$382,130
Northwestern University · · FY2010 · Department of the Army

Multiparametric Photoacoustic Imaging-Based Identification of Aggressive Prostate Cancer

$382,110
Haichong Zhang · Worcester Polytechnic Institute · DP5 · FY2019 · OD

Targeting the colchicine binding site in tubulin for cancer therapy

$382,020
Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA

The role of autophagy in cadmium induced prostate carcinogenesis

$382,018
Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2021 · ES

Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis

$382,013
Edward L Schwartz · Albert Einstein College Of Medicine · R01 · FY2020 · CA

Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis

$382,013
Liang Zhu · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA

Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis

$382,013
Liang Zhu · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA

NCTN - Network Lead Academic Participating Site: USC

$381,932
Heinz Josef Lenz · University Of Southern California · UG1 · FY2023 · CA

Integrin alpha6beta4 Signaling in Prostate Carcinoma Growth and Invasion

$381,906
Filippo G Giancotti · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA

Role of alpha6 beta1 Integrin in Prostate Cancer

$381,906
Cynthia K Miranti · Van Andel Research Institute · R01 · FY2015 · CA

Role of PALB2 in the DNA Damage Response and Cancer Suppression

$381,862
Bing Xia · Rutgers Biomedical And Health Sciences · R01 · FY2022 · CA

EARLY DETECTION OF CANCER BY AFFINITY MASS SPECTROMETRY

$381,824
Eastern Virginia Medical School · U01 · FY2000 · CA

Community Outreach and Engagement

$381,804
Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2022 · CA

PROSTATE CANCER--FAMILY CARE FOR PATIENTS AND SPOUSES

$381,801
University Of Michigan At Ann Arbor · R01 · FY2005 · CA

Elucidating a novel molecular biomarker for castration-resistant prostate cancer

$381,781
Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · CA